meRfi®-GM
Alfa-galactosylceramide (alfa-GalCer)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Alfa-galactosylceramide (alfa-GalCer) as a strong agonist selective for iNKT cells
Alfa-galactosylceramide (alfa-GalCer) presented to Natural Killer T cell (NKT-Cell) by CD1d molecules
Alfa-galactosylceramide (alfa-GalCer) acts as an adjuvant for CD8 T cell–dependent protection against malaria
…
References (Sources)
- Activation of Natural Killer T Cells by -Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
- Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes
- Vaccines adjuvanted with an NKT cell agonist induce effective T-cell responses in models of CNS lymphoma